Corvus Pharmaceuticals Inc (CRVS)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -30.489 | -47.388 | -44.073 | -46.238 | -7.087 | -44.353 | -46.492 | -47.506 |
Return on Equity (%) | -71.534 | -51.152 | -48.1 | -51.444 | -8.369 | -51.079 | -53.898 | -57.024 |
Return on Invested Capital (%) | -74.041 | -52.362 | -50.786 | -54.141 | -83.713 | -89.454 | -87.983 | -101.416 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 3.773 | 4.032 | 3.763 | 2.544 | 2.543 | 2.087 | 1.205 | 0.789 |
Earnings Per Share | -1.033 | -2.645 | -1.601 | -1.67 | -0.211 | -0.929 | -0.887 | -0.551 |
Cash Per Share | 0.143 | 2.144 | 1.337 | 0.184 | 0.58 | 1.363 | 0.283 | 0.257 |
Working Capital Per Share | 3.696 | 3.91 | 3.702 | 2.473 | 1.17 | 1.324 | 0.707 | 0.43 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.033 | -2.645 | -1.601 | -1.67 | -0.211 | -0.929 | -0.887 | -0.551 |
EBITDA Per Share | -1.033 | -2.645 | -1.601 | -1.67 | -0.211 | -0.929 | -0.887 | -0.551 |
Free Cash Flow Per Share | -0.988 | -2.673 | -1.617 | -1.695 | -0.231 | -0.939 | -0.889 | -0.554 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 20,92M | 21,04M | 29,32M | 27,95M | 28,37M | 46,55M | 46,55M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 46,55M | N/A | 48,9M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 303,94M |
Ratio cours/bénéfice | -11,89 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 25,46 |
Ratio prix/valeur comptable | 8,31 |
Rendement de dividende | - |
Actions en circulation | 64,26M |
Volume moyen (1 semaine) | 654,68k |
Volume moyen (1 mois) | 881,05k |
Variation sur 52 semaines | 131,92% |
Plus haut sur 52 semaines | 10,00 |
Plus bas sur 52 semaines | 1,30 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales